Mary Carrington

Mary Carrington Mary N. Carrington is an American immunologist researching the role of host genetics in cancer, autoimmunity and infectious disease pathogenesis. She is director of the basic science program and head of the HLA Immunogenetics section at the Frederick National Laboratory for Cancer Research. Provided by Wikipedia
Showing 1 - 20 results of 22 for search 'Mary Carrington', query time: 0.03s Refine Results
  1. 1
    Statistical resolution of ambiguous HLA typing data.

    Statistical resolution of ambiguous HLA typing data. by Jennifer Listgarten, Zabrina Brumme, Carl Kadie, Gao Xiaojiang, Bruce Walker, Mary Carrington, Philip Goulder, David Heckerman

    Published 2008-02-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function.

    HLA-Cw*0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function. by Lena Fadda, Christian Körner, Swati Kumar, Nienke H van Teijlingen, Alicja Piechocka-Trocha, Mary Carrington, Marcus Altfeld

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    KIR/HLA pleiotropism: protection against both HIV and opportunistic infections.

    KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. by Ying Qi, Maureen P Martin, Xiaojiang Gao, Lisa Jacobson, James J Goedert, Susan Buchbinder, Gregory D Kirk, Stephen J O'Brien, John Trowsdale, Mary Carrington

    Published 2006-08-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motif.

    KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motif. by Arnaud D Colantonio, Benjamin N Bimber, William J Neidermyer, R Keith Reeves, Galit Alter, Marcus Altfeld, R Paul Johnson, Mary Carrington, David H O'Connor, David T Evans

    Published 2011-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody.

    IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody. by Simone I Richardson, Bronwen E Lambson, Andrew R Crowley, Arman Bashirova, Cathrine Scheepers, Nigel Garrett, Salim Abdool Karim, Nonhlanhla N Mkhize, Mary Carrington, Margaret E Ackerman, Penny L Moore, Lynn Morris

    Published 2019-12-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial.

    Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial. by Jonathan Z Li, Chanson J Brumme, Michael M Lederman, Zabrina L Brumme, Hongying Wang, John Spritzler, Mary Carrington, Kathleen Medvik, Bruce D Walker, Robert T Schooley, Daniel R Kuritzkes, AIDS Clinical Trials Group A5197 Study Team

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV.

    Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV. by Christopher Chiu, Megan McCausland, John Sidney, Fuh-Mei Duh, Nadine Rouphael, Aneesh Mehta, Mark Mulligan, Mary Carrington, Andreas Wieland, Nicole L Sullivan, Adriana Weinberg, Myron J Levin, Bali Pulendran, Bjoern Peters, Alessandro Sette, Rafi Ahmed

    Published 2014-03-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    A novel system of polymorphic and diverse NK cell receptors in primates.

    A novel system of polymorphic and diverse NK cell receptors in primates. by Anne Averdam, Beatrix Petersen, Cornelia Rosner, Jennifer Neff, Christian Roos, Manfred Eberle, Fabienne Aujard, Claudia Münch, Werner Schempp, Mary Carrington, Takashi Shiina, Hidetoshi Inoko, Florian Knaust, Penny Coggill, Harminder Sehra, Stephan Beck, Laurent Abi-Rached, Richard Reinhardt, Lutz Walter

    Published 2009-10-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection.

    KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. by Nafisa-Katrin Seich Al Basatena, Aidan Macnamara, Alison M Vine, Chloe L Thio, Jacquie Astemborski, Koichiro Usuku, Mitsuhiro Osame, Gregory D Kirk, Sharyne M Donfield, James J Goedert, Charles R M Bangham, Mary Carrington, Salim I Khakoo, Becca Asquith

    Published 2011-10-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.

    HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. by Marcus Altfeld, Elizabeth T Kalife, Ying Qi, Hendrik Streeck, Mathias Lichterfeld, Mary N Johnston, Nicole Burgett, Martha E Swartz, Amy Yang, Galit Alter, Xu G Yu, Angela Meier, Juergen K Rockstroh, Todd M Allen, Heiko Jessen, Eric S Rosenberg, Mary Carrington, Bruce D Walker

    Published 2006-10-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease.

    Psoriasis patients are enriched for genetic variants that protect against HIV-1 disease. by Haoyan Chen, Genki Hayashi, Olivia Y Lai, Alexander Dilthey, Peter J Kuebler, Tami V Wong, Maureen P Martin, Marcelo A Fernandez Vina, Gil McVean, Matthias Wabl, Kieron S Leslie, Toby Maurer, Jeffrey N Martin, Steven G Deeks, Mary Carrington, Anne M Bowcock, Douglas F Nixon, Wilson Liao

    Published 2012-02-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove.

    The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove. by Minzhong Tang, James A Lautenberger, Xiaojiang Gao, Efe Sezgin, Sher L Hendrickson, Jennifer L Troyer, Victor A David, Li Guan, Carl E McIntosh, Xiuchan Guo, Yuming Zheng, Jian Liao, Hong Deng, Michael Malasky, Bailey Kessing, Cheryl A Winkler, Mary Carrington, Guy Dé The, Yi Zeng, Stephen J O'Brien

    Published 2012-01-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection.

    Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection. by Emily Adland, Paolo Paioni, Christina Thobakgale, Leana Laker, Luisa Mori, Maximilian Muenchhoff, Anna Csala, Margaret Clapson, Jacquie Flynn, Vas Novelli, Jacob Hurst, Vanessa Naidoo, Roger Shapiro, Kuan-Hsiang Gary Huang, John Frater, Andrew Prendergast, Julia G Prado, Thumbi Ndung'u, Bruce D Walker, Mary Carrington, Pieter Jooste, Philip J R Goulder

    Published 2015-06-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects.

    Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. by Nikolaos A Patsopoulos, Lisa F Barcellos, Rogier Q Hintzen, Catherine Schaefer, Cornelia M van Duijn, Janelle A Noble, Towfique Raj, IMSGC, ANZgene, Pierre-Antoine Gourraud, Barbara E Stranger, Jorge Oksenberg, Tomas Olsson, Bruce V Taylor, Stephen Sawcer, David A Hafler, Mary Carrington, Philip L De Jager, Paul I W de Bakker

    Published 2013-11-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history.

    Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. by James A Traherne, Roger Horton, Anne N Roberts, Marcos M Miretti, Matthew E Hurles, C Andrew Stewart, Jennifer L Ashurst, Alexey M Atrazhev, Penny Coggill, Sophie Palmer, Jeff Almeida, Sarah Sims, Laurens G Wilming, Jane Rogers, Pieter J de Jong, Mary Carrington, John F Elliott, Stephen Sawcer, John A Todd, John Trowsdale, Stephan Beck

    Published 2006-01-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults.

    An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune contro... by Vinicius A Vieira, Emily Adland, David F G Malone, Maureen P Martin, Andreas Groll, M Azim Ansari, Maria C Garcia-Guerrero, Mari C Puertas, Maximilian Muenchhoff, Claudia Fortuny Guash, Christian Brander, Javier Martinez-Picado, Alasdair Bamford, Gareth Tudor-Williams, Thumbi Ndung'u, Bruce D Walker, Veron Ramsuran, John Frater, Pieter Jooste, Dimitra Peppa, Mary Carrington, Philip J R Goulder

    Published 2021-11-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa.

    Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South... by Angelique Hölzemer, Christina F Thobakgale, Camilo A Jimenez Cruz, Wilfredo F Garcia-Beltran, Jonathan M Carlson, Nienke H van Teijlingen, Jaclyn K Mann, Manjeetha Jaggernath, Seung-gu Kang, Christian Körner, Amy W Chung, Jamie L Schafer, David T Evans, Galit Alter, Bruce D Walker, Philip J Goulder, Mary Carrington, Pia Hartmann, Thomas Pertel, Ruhong Zhou, Thumbi Ndung'u, Marcus Altfeld

    Published 2015-11-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Copy number variation of KIR genes influences HIV-1 control.

    Copy number variation of KIR genes influences HIV-1 control. by Kimberly Pelak, Anna C Need, Jacques Fellay, Kevin V Shianna, Sheng Feng, Thomas J Urban, Dongliang Ge, Andrea De Luca, Javier Martinez-Picado, Steven M Wolinsky, Jeremy J Martinson, Beth D Jamieson, Jay H Bream, Maureen P Martin, Persephone Borrow, Norman L Letvin, Andrew J McMichael, Barton F Haynes, Amalio Telenti, Mary Carrington, David B Goldstein, Galit Alter, NIAID Center for HIV/AIDS Vaccine Immunology

    Published 2011-11-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    LILRB2 interaction with HLA class I correlates with control of HIV-1 infection.

    LILRB2 interaction with HLA class I correlates with control of HIV-1 infection. by Arman A Bashirova, Enrique Martin-Gayo, Des C Jones, Ying Qi, Richard Apps, Xiaojiang Gao, Patrick S Burke, Craig J Taylor, Jerome Rogich, Steven Wolinsky, Jay H Bream, Priya Duggal, Shehnaz Hussain, Jeremy Martinson, Amy Weintrob, Gregory D Kirk, Jacques Fellay, Susan P Buchbinder, James J Goedert, Steven G Deeks, Florencia Pereyra, John Trowsdale, Mathias Lichterfeld, Amalio Telenti, Bruce D Walker, Rachel L Allen, Mary Carrington, Xu G Yu

    Published 2014-03-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic.

    Genotypic and functional impact of HIV-1 adaptation to its host population during the North American epidemic. by Laura A Cotton, Xiaomei T Kuang, Anh Q Le, Jonathan M Carlson, Benjamin Chan, Denis R Chopera, Chanson J Brumme, Tristan J Markle, Eric Martin, Aniqa Shahid, Gursev Anmole, Philip Mwimanzi, Pauline Nassab, Kali A Penney, Manal A Rahman, M-J Milloy, Martin T Schechter, Martin Markowitz, Mary Carrington, Bruce D Walker, Theresa Wagner, Susan Buchbinder, Jonathan Fuchs, Beryl Koblin, Kenneth H Mayer, P Richard Harrigan, Mark A Brockman, Art F Y Poon, Zabrina L Brumme

    Published 2014-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: